Loading
A phase 1/2 trial of SHR-8068 and adebrelimab in colorectal cancer, run by West China Hospital, not yet recruiting.
SHR-8068 Combined With Adbelizumab and BP102 in the Treatment of Advanced Colorectal Cancer is a phase 1/2, interventional study registered as NCT06373133 by West China Hospital, with a registry enrolment figure of 36 participants, started 2024-05-01 and due to reach its primary completion in 2026-11-01. Interventions recorded: SHR-8068; Adebrelimab; BP102. Conditions listed: Colorectal Cancer. Primary outcome: Dose-limiting toxicity; PFS. Colorectal eligibility wording from the registry: "pathologically confirmed metastatic colorectal adenocarcinoma;". No results are recorded here; the registry entry is the source.
Shares Adebrelimab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Adebrelimab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Adebrelimab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.